Flow cytometric analysis identified a monotypic B cell population that expressed CD5, CD19, CD20, CD22, CD23, and kappa, consistent with chronic lymphocytic leukemia (CLL). This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.